Read More News Elon Musk And Twitter Continue Talks On Closing Deal, May Have Agreement As Early As Wednesday By Benzinga Newsdesk October 5, 12:35 PM - Reuters Citing Source TWTR
Read More Analyst Ratings News Price Target Truist Securities Maintains Hold on Okta, Lowers Price Target to $140 By Benzinga Newsdesk July 26, 8:07 AM Truist Securities analyst Joel Fishbein maintains Okta (NASDAQ:OKTA) with a Hold and lowers the price target from $170 to $140. OKTA
Read More Biotech General News LAVA Therapeutics Announces Selection By Janssen Of Lead Gamma-Delta T-Cell Engager Bispecific Antibody To Move Toward Clinical Development By Happy Mohamed June 1, 4:22 PM Through a research collaboration with Janssen, a lead candidate was identified for further development towards clinical studies. In May 2020, LAVA entered into a research collaboration and license agreement JNJ
Read More Cryptocurrency Markets News Top Stories Analyst Predicts Bold Future For Bitcoin Amid Major Move From Central Banks By Bibhu Pattnaik March 18, 10:06 AM Arthur Hayes, co-founder and former CEO of crypto derivatives trading platform BitMEX, is forecasting a massive rally for Bitcoin (CRYPTO: BTC), BTC